Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A roGFP1-iL carrying the mutations S147CL and H148S has been reported to have the least negative midpoint potential (229 5 mV) of a whole series or roGFP1-iX variants (Lohman and Remington, 2008)
The SBP-tag enabled binding to NeutrAvidin beads, which facilitated treatment with Na 2 S 2 , followed by washing and processing without precipitation and resuspension of the protein (Supplementary Fig
Please arrive 15 minutes before your appointment
It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes
In: The Third International Conference on the Development of Biomedical Engineering in Vietnam: BME2010, 11-14 January, 2010, Ho Chi Minh City, Vietnam
Studies suggest it may lower markers of muscle damage, like creatine kinase, after intense exercise
